| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| B6R (MPXV) | Monkeypox virus (Democratic Republic of the Congo) B6R Protein, His Tag (MALS verified) | Monkeypox virus (Democratic Republic of the Congo) | HEK293 | MALSSDS-PAGE | $465.00 50ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Branaplam | LMI-070; NVS-SM1 | Phase 2 Clinical | Novartis Pharma Ag | Huntington Disease; Muscular Atrophy, Spinal | Details |
| vesemnogene lantuparvovec (Lantu Biopharma) | AAV-hSMN1 | Phase 2 Clinical | Lantu Biopharma Inc | Muscular Atrophy, Spinal | Details |
| EXG001-307 | EXG001-307 | Phase 2 Clinical | Hangzhou Jiayin Biotechnology Co Ltd | Muscular Atrophy, Spinal | Details |
| SMN-C3 | SMN-C3 | Phase 1 Clinical | Ptc Therapeutics Inc, F. Hoffmann-La Roche Ltd | Muscular Atrophy, Spinal | Details |
| SKG-0201 | SKG0201; SKG-0201 | Phase 1 Clinical | Skyline Therapeutics (Hong Kong) Ltd | Spinal Muscular Atrophies of Childhood; Muscular Atrophy, Spinal | Details |
| BIIB-115 | BIIB-115; ION-306 | Phase 1 Clinical | Ionis Pharmaceuticals Inc | Muscular Atrophy, Spinal | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Risdiplam | RG-7916; RO-7034067 | Approved | Ptc Therapeutics Inc | EVRYSDI, 艾满欣 | United States | Muscular Atrophy, Spinal | Genentech Inc | 2020-08-07 | Muscular Atrophy, Spinal | Details |
| Nusinersen sodium | BIIB-058; ISIS-396443 | Approved | Ionis Pharmaceuticals Inc, Biogen Inc | Spinraza | United States | Muscular Atrophy, Spinal | Biogen Idec | 2016-12-23 | Muscular Atrophy, Spinal | Details |
| Onasemnogene abeparvovec | rAAV-9; AVXS-101; scAAV-9.CB.SMN; OAV101 | Approved | Novartis Gene Therapies Inc, Novartis Pharma Ag | Zolgensma | United States | Muscular Atrophy, Spinal | Novartis Gene Therapies Inc | 2019-05-24 | Spinal Muscular Atrophies of Childhood; Muscular Atrophy, Spinal | Details |
